Page last updated: 2024-09-03

3-n-methylspiperone and quetiapine fumarate

3-n-methylspiperone has been researched along with quetiapine fumarate in 1 studies

Compound Research Comparison

Studies (3-n-methylspiperone)	Trials (3-n-methylspiperone)	Recent Studies (post-2010) (3-n-methylspiperone)	Studies (quetiapine fumarate)	Trials (quetiapine fumarate)	Recent Studies (post-2010) (quetiapine fumarate)
155	6	7	3,162	619	1,456

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergström, M; Gefvert, O; Hagberg, G; Långström, B; Lindström, L; Wiesel, FA; Wieselgren, IM	1

Trials

1 trial(s) available for 3-n-methylspiperone and quetiapine fumarate

Article	Year
N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry research, 1998, Jun-30, Volume: 82, Issue:3 Topics: Adult; Antipsychotic Agents; Caudate Nucleus; Cerebellum; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Humans; Male; Putamen; Quetiapine Fumarate; Raclopride; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed	1998

Article

Year

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.

Psychiatry research, 1998, Jun-30, Volume: 82, Issue:3

Topics: Adult; Antipsychotic Agents; Caudate Nucleus; Cerebellum; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Humans; Male; Putamen; Quetiapine Fumarate; Raclopride; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Spiperone; Tomography, Emission-Computed

1998